Recent Posts
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
- Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
- Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs
- Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.
- Cycle Pharmaceuticals Partners with Cardinal as the Logistic Provider for Nityr in U.S.
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
- Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
- Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs
- Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.
- Cycle Pharmaceuticals Partners with Cardinal as the Logistic Provider for Nityr in U.S.
Recent Tweets
-
Our next feature-rich Avada update is being wrapped up & will be ready for release in a few sleeps. Element updates… twitter.com/i/web/status/1…
7 hours ago -
@CRhodesDesign Please create a support ticket bit.ly/2njyfVo and our team will gladly assist and guide yo… twitter.com/i/web/status/1…
7 hours ago -
@mcdesignsie Please create a support ticket bit.ly/2njyfVo and our team will gladly assist and guide you.
13 hours ago
Recent Comments